Literature DB >> 9809716

From the Food and Drug Administration.

S L Nightingale.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9809716

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Authors:  Susan B Brogly; Mark J Abzug; D Heather Watts; Coleen K Cunningham; Paige L Williams; James Oleske; Daniel Conway; Rhoda S Sperling; Hans Spiegel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

Review 2.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  HIV antiretroviral therapy in resource-limited settings: experiences from Haiti.

Authors:  Alysa Krain; Daniel W Fitzgerald
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

Review 4.  Prevention of perinatal HIV transmission: the Perinatal HIV Hotline perspective.

Authors:  Jess Fogler Waldura
Journal:  Top Antivir Med       Date:  2011 Feb-Mar

5.  Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

Authors:  D Heather Watts; Sharon Huang; Mary Culnane; Kathleen A Kaiser; Angela Scheuerle; Lynne Mofenson; Kenneth Stanley; Marie-Louise Newell; Laurent Mandelbrot; Jean-Francois Delfraissy; Coleen K Cunningham
Journal:  J Perinat Med       Date:  2010-12-13       Impact factor: 1.901

6.  CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

Authors:  Ayotunde James; Babatunde Oluwatosin; Georgina Njideka; Onyekwere George Benjamin; David Olufemi; Robert Leo; Isaac Folorunso; Olusegun Olusina
Journal:  Oral Surg       Date:  2014-12

Review 7.  Teratogenicity risk of antiretroviral therapy in pregnancy.

Authors:  D Heather Watts
Journal:  Curr HIV/AIDS Rep       Date:  2007-08       Impact factor: 5.071

Review 8.  Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.

Authors:  Kristina Thorsteinsson; Steen Ladelund; Søren Jensen-Fangel; Isik Somuncu Johansen; Terese L Katzenstein; Gitte Pedersen; Merete Storgaard; Niels Obel; Anne-Mette Lebech
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

10.  Safety and tolerability of antiretrovirals during pregnancy.

Authors:  Adriana Weinberg; Jeri Forster-Harwood; Jill Davies; Elizabeth J McFarland; Jennifer Pappas; Kay Kinzie; Emily Barr; Suzanne Paul; Carol Salbenblatt; Elizabeth Soda; Anna Vazquez; Myron J Levin
Journal:  Infect Dis Obstet Gynecol       Date:  2011-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.